This study is exploring if a new medicine called **ziltivekimab** can help people with heart failure and inflammation. Heart failure is when the heart can't pump blood as well as it should. Inflammation is when the body is swollen or irritated. Participants will either receive ziltivekimab or a placebo, which is a fake treatment that looks like the real medicine but doesn’t contain any medicine. The selection is done randomly, like flipping a coin. The study lasts up to 1 year and 4 months. Ziltivekimab is not approved by doctors yet, so this study will help see if it works. To join, participants must meet specific health criteria, like certain heart conditions and blood test results.
- The study lasts for up to 1 year and 4 months.
- Participants will be randomly assigned to receive either ziltivekimab or a placebo.
- Participants need to meet specific health criteria to be eligible.
How understandable was the trial content above?
Hard to understand
Easy to understand